Design of histamine H3-receptor agonists and antagonists Walter SchunackHolger Stark OriginalPaper Pages: 173 - 178
Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders E. CeredaA. BrambillaA. Sagrada OriginalPaper Pages: 179 - 183
The design of potential antidiabetic drugs: experimental investigation of a number of β-D-glucose analogue inhibitors of glycogen phosphorylase N. G. OikonomakosM. KontouK. R. Acharya OriginalPaper Pages: 185 - 192
Design of drugs through a consideration of drug metabolism and pharmacokinetics Dennis A. Smith OriginalPaper Pages: 193 - 199
The metabolism of alicyclic amines to reactive iminium ion intermediates J. W. GorrodG. Aislaitner OriginalPaper Pages: 209 - 217
Molecular toxicology of peroxisome proliferators Fiona McNaeRaj SharmaG. Gordon Gibson OriginalPaper Pages: 219 - 223
The use of computers in the safety evaluation of drugs and other chemicals Costas IoannidesDavid F. V. LewisDennis V. Parke OriginalPaper Pages: 225 - 233
Capillary electrophoresis and Capillary Electrophoresis-mass spectrometry in drug and metabolite analysis Stephen NaylorAndy J. TomlinsonJohn W. Gorrod OriginalPaper Pages: 235 - 240
Enantiospecific analysis: Applications in bioanalysis and metabolism A. J. HuttM. R. HadleyS. C. Tan OriginalPaper Pages: 241 - 251
Surfactant systems: Microemulsions and vesicles as vehicles for drug delivery M Jayne Lawrence OriginalPaper Pages: 257 - 269
Bioequivalency evaluation by comparison ofin vitro dissolution andin vivo absorption using reference equations A. Kayali OriginalPaper Pages: 271 - 277
Plasma levels and therapeutic response: The relevance to community pharmacy Terry Maguire OriginalPaper Pages: 279 - 281
Are we doing too many animal biodisposition investigations before Phase I studies in man? D. B. Campbell OriginalPaper Pages: 283 - 293
